TWI533875B - Rutin-rich extract and method of making same - Google Patents
Rutin-rich extract and method of making same Download PDFInfo
- Publication number
- TWI533875B TWI533875B TW101138967A TW101138967A TWI533875B TW I533875 B TWI533875 B TW I533875B TW 101138967 A TW101138967 A TW 101138967A TW 101138967 A TW101138967 A TW 101138967A TW I533875 B TWI533875 B TW I533875B
- Authority
- TW
- Taiwan
- Prior art keywords
- extract
- rutin
- alcohol
- acid
- water
- Prior art date
Links
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 title claims description 72
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 title claims description 72
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 title claims description 72
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 title claims description 72
- 235000005493 rutin Nutrition 0.000 title claims description 72
- 229960004555 rutoside Drugs 0.000 title claims description 72
- 239000000284 extract Substances 0.000 title claims description 63
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 title claims 9
- 238000004519 manufacturing process Methods 0.000 title 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 61
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 60
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 50
- 238000000034 method Methods 0.000 claims description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 36
- 239000000243 solution Substances 0.000 claims description 34
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 32
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 28
- 229910052742 iron Inorganic materials 0.000 claims description 25
- 239000002253 acid Substances 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 18
- 239000000419 plant extract Substances 0.000 claims description 17
- 239000011668 ascorbic acid Substances 0.000 claims description 16
- 235000010323 ascorbic acid Nutrition 0.000 claims description 16
- 229960005070 ascorbic acid Drugs 0.000 claims description 16
- 241000196324 Embryophyta Species 0.000 claims description 13
- 238000002835 absorbance Methods 0.000 claims description 10
- 239000012141 concentrate Substances 0.000 claims description 10
- 229940007062 eucalyptus extract Drugs 0.000 claims description 10
- 239000002244 precipitate Substances 0.000 claims description 10
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 10
- 241000402754 Erythranthe moschata Species 0.000 claims description 7
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 6
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 5
- 235000002906 tartaric acid Nutrition 0.000 claims description 5
- 239000011975 tartaric acid Substances 0.000 claims description 5
- 241000157352 Uncaria Species 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 244000166124 Eucalyptus globulus Species 0.000 claims 1
- UQOFGTXDASPNLL-XHNCKOQMSA-N Muscarine Chemical compound C[C@@H]1O[C@H](C[N+](C)(C)C)C[C@H]1O UQOFGTXDASPNLL-XHNCKOQMSA-N 0.000 claims 1
- 241000840095 Oxyethira serrata Species 0.000 claims 1
- ANVAOWXLWRTKGA-XHGAXZNDSA-N all-trans-alpha-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C ANVAOWXLWRTKGA-XHGAXZNDSA-N 0.000 claims 1
- 235000005473 carotenes Nutrition 0.000 claims 1
- 235000021466 carotenoid Nutrition 0.000 claims 1
- 150000001747 carotenoids Chemical class 0.000 claims 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 65
- 239000007787 solid Substances 0.000 description 19
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 10
- 239000002904 solvent Substances 0.000 description 9
- 239000013078 crystal Substances 0.000 description 7
- 238000002425 crystallisation Methods 0.000 description 7
- 230000008025 crystallization Effects 0.000 description 7
- 238000001914 filtration Methods 0.000 description 7
- 241000219927 Eucalyptus Species 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- 235000004515 gallic acid Nutrition 0.000 description 5
- 229940074391 gallic acid Drugs 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 4
- 235000015165 citric acid Nutrition 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000001630 malic acid Substances 0.000 description 4
- 235000011090 malic acid Nutrition 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 239000012088 reference solution Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 241001022534 Ellipticus Species 0.000 description 2
- IKGXIBQEEMLURG-UHFFFAOYSA-N Rutin Chemical compound OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-UHFFFAOYSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000000287 crude extract Substances 0.000 description 2
- 150000004683 dihydrates Chemical class 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 150000004682 monohydrates Chemical class 0.000 description 2
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 2
- 235000019799 monosodium phosphate Nutrition 0.000 description 2
- ZJQHPWUVQPJPQT-UHFFFAOYSA-N muscimol Chemical compound NCC1=CC(=O)NO1 ZJQHPWUVQPJPQT-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 150000004684 trihydrates Chemical class 0.000 description 2
- 229960003232 troxerutin Drugs 0.000 description 2
- 206010048591 Post thrombotic syndrome Diseases 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- 244000046101 Sophora japonica Species 0.000 description 1
- 235000010586 Sophora japonica Nutrition 0.000 description 1
- 244000056892 Uncaria elliptica Species 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229960004676 antithrombotic agent Drugs 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 229940099690 malic acid Drugs 0.000 description 1
- 210000004088 microvessel Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- -1 octyl sulfonyl group Chemical group 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 229960001367 tartaric acid Drugs 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
一種從植物獲得富芸香素萃取物的方法及如此獲得之橢圓葉鈎藤(Uncaria elliptica)的富芸香素萃取物。 A method for obtaining a rutin-rich extract from a plant and a eucalyptus-rich extract of Uncaria elliptica thus obtained.
芸香素係一種天然類黃酮,其使用作為曲克蘆丁(Troxerutin)的起始物質,其中曲克蘆丁可增加微血管的耐力及降低靜脈血管壁的通透性。臨床研究顯示出以芸香素衍生物(維腦路通(venoruton))治療患者導致改善血栓後症候群。參見Panminerva Medicine,53,第13頁,2011。另一個研究發現芸香素係最有效的抗血栓劑之一。參見The Journal of Clinical Investigation,122,No 6,2012。芸香素作為醫藥品的起始物質漸漸變得更重要。 Mutin is a natural flavonoid used as a starting material for Troxerutin, which increases the tolerance of microvessels and reduces the permeability of venous blood vessel walls. Clinical studies have shown that treatment of patients with rutinu derivatives (venoruton) leads to improved post-thrombotic syndrome. See Panminerva Medicine, 53, page 13, 2011. Another study found that rutin is one of the most effective antithrombotic agents. See The Journal of Clinical Investigation, 122, No 6, 2012. As a starting material for pharmaceuticals, ruthenium is becoming more important.
為了從多種植物來源(例如,槐樹(Sophora Japonica)(亞洲)、Fava d’anta(巴西)及橢圓葉鈎藤(巴西))萃取及純化出芸香素,典型使用水及甲醇溶劑。但是,實際上來自此等植物來源的富芸香素萃取物具有明顯的缺點,諸如濃棕色及包含較高的鐵含量(與來自其它來源的富芸香素萃取物比較)。此棕色歸因於植物中的色素。 In order to extract and purify rutin from a variety of plant sources (for example, Sophora Japonica (Asia), Fava d'anta (Brazil) and Ellipticus (Brazil)), water and methanol solvents are typically used. However, in fact, the eucalyptus extracts from such plant sources have significant disadvantages, such as rich brown color and high iron content (compared to eucalyptus extracts from other sources). This brown is attributed to the pigment in the plant.
非常難以藉由習知的萃取及/或純化方法消除此棕色及減少鐵含量,因為鐵顯示出係緊緊地併入該色素中。已經嘗試克服這些缺點。但是,這些嘗試難以減少已併入色素中的鐵同時維持好的芸香素產率。 It is very difficult to eliminate this brown and reduce the iron content by conventional extraction and/or purification methods because iron is shown to be tightly incorporated into the pigment. Attempts have been made to overcome these disadvantages. However, these attempts have made it difficult to reduce the iron that has been incorporated into the pigment while maintaining a good muskene yield.
對合適於大規模生產具有高芸香素含量、低鐵含量及減低呈色之富芸香素萃取物的應用之經濟程序有需求。 There is a need for an economic process suitable for the large-scale production of eucalyptus extracts having high arsenic content, low iron content and reduced coloration.
本發明係以可使用特別的醇與酸之組合來從植物獲得低鐵含量及呈色的富芸香素萃取物之出乎意料的發現為基礎。 The present invention is based on the unexpected discovery that a combination of a particular alcohol and an acid can be used to obtain a low iron content and coloured eucalyptus extract from plants.
此外,於本文中描述出一種從植物獲得一富芸香素萃取物的方法。該方法包括將一含芸香素植物萃取物溶解在甲醇或乙醇中以獲得一粗芸香素萃取物溶液,其中該含固體芸香素植物萃取物包含90%至95重量%的芸香素及100至300 ppm的鐵;減少該粗芸香素萃取物溶液的體積以獲得一濃縮物;藉由將一酸(1-15%,以該含芸香素植物萃取物的重量計)、及選擇性C1-C4醇、水或二者加入至該濃縮物獲得一混合物,其中該含芸香素植物萃取物構成該混合物的8%至30%(w/v)及該酸係選自於由抗壞血酸、檸檬酸、酒石酸、沒食子酸及蘋果酸所組成之群;讓該混合物靜置以形成沉澱;及分離出該沉澱物,因此獲得一包含少於20 ppm的鐵之富芸香素萃取物。 Additionally, a method of obtaining a rutin-rich extract from a plant is described herein. The method comprises dissolving a rutin-containing plant extract in methanol or ethanol to obtain a crude rutin extract solution, wherein the solid rutin-containing plant extract comprises 90% to 95% by weight of rutin and 100 to 300 Ppm of iron; reducing the volume of the crude rutin extract solution to obtain a concentrate; by using an acid (1-15% by weight of the rutin-containing plant extract), and selective C1-C4 An alcohol, water or both is added to the concentrate to obtain a mixture, wherein the musk-containing plant extract constitutes 8% to 30% (w/v) of the mixture and the acid is selected from ascorbic acid, citric acid, a group consisting of tartaric acid, gallic acid, and malic acid; allowing the mixture to stand to form a precipitate; and separating the precipitate, thereby obtaining an iron-rich eucalyptus extract containing less than 20 ppm.
該含芸香素植物萃取物可從以水、醇或醇水溶液萃取橢圓葉鈎藤、槐樹或Fava d’anta獲得,如為粗沉澱物。 The musk-containing plant extract can be obtained by extracting an elliptic leaf vine, eucalyptus or Fava d'anta with water, an alcohol or an aqueous alcohol solution, such as a coarse precipitate.
在某些具體實例中,該酸係以1-10%(以該含芸香素植物萃取物的重量計)加入,例如,1-5%或2-4%。在加入水與C1-C4醇的情況中,該水對C1-C4醇之比率可係1:1 至5:1,例如,1:1至3:1。水與C1-C4醇可分別、同時或以C1-C4醇水溶液之形式加入。 In certain embodiments, the acid is added in an amount of from 1 to 10% by weight of the musk-containing plant extract, for example, 1-5% or 2-4%. In the case of adding water and a C1-C4 alcohol, the ratio of the water to the C1-C4 alcohol can be 1:1. To 5:1, for example, 1:1 to 3:1. The water and the C1-C4 alcohol may be added separately, simultaneously or in the form of an aqueous solution of a C1-C4 alcohol.
同樣地,本文的特色為一種橢圓葉鈎藤的富芸香素萃取物,該萃取物包含97%至99%芸香素(如藉由HPLC測量)及少於20 ppm的鐵,該萃取物在550奈米處的吸收度係低於0.2。該萃取物亦可包含5%至10重量%的水。其可藉由上述方法製備。 Similarly, a feature of this article is a eucalyptus extract of Uncaria sylvestris, which contains 97% to 99% of rutin (as measured by HPLC) and less than 20 ppm of iron. The extract is at 550. The absorbance at the nano is less than 0.2. The extract may also contain from 5% to 10% by weight of water. It can be prepared by the above method.
在下列說明中提出本發明的一或多個具體實例之細節。將從該說明及從申請專利範圍明瞭本發明的其它特徵、目標及優點。 The details of one or more specific embodiments of the invention are set forth in the description below. Other features, objects, and advantages of the invention will be apparent from the description and appended claims.
於本文中描述出一種使用新穎的醇與酸之組合,從植物來源獲得富芸香素萃取物的方法。如與藉由習知方法製備的萃取物比較,藉由本方法獲得之富芸香素萃取物已明顯減低呈色及鐵含量。 A method of obtaining a rutin-rich extract from a plant source using a novel combination of an alcohol and an acid is described herein. The eucalyptus extract obtained by the method has significantly reduced the coloration and iron content as compared to the extract prepared by the conventional method.
該含固體芸香素萃取物可使用在技藝中已知的習知方法,從多種植物來源製備,例如,槐樹(亞洲)、Fava d’anta(巴西)及橢圓葉鈎藤(巴西)。此方法包括(但不限於)在多種溶劑中浸泡、加熱、搖晃、攪拌或注入植物材料(例如,莖及葉)。所使用的植物材料可呈整株乾燥植物、壓碎的植物或粉末形式。該溶劑包括水、醇(例如,甲醇)或醇水溶液。在萃取後,該萃取物溶液可藉由篩選、過濾、加壓或其它合適的技術與固體分離。該濾出液可經濃縮及冷卻以允許 形成沉澱,因此獲得一含固體芸香素萃取物。多種萃取方法之說明參見例如,Chinese Patent 1013579;US 2006/0099690;及Dighe等人,International Journal of Pharma and Bio Sciences,2(1):750-757(2011)。 The solid gum-containing extract can be prepared from a variety of plant sources using conventional methods known in the art, for example, Eucalyptus (Asia), Fava d'anta (Brazil), and Ellipticus (Brazil). Such methods include, but are not limited to, soaking, heating, shaking, stirring, or injecting plant material (eg, stems and leaves) in a variety of solvents. The plant material used may be in the form of a whole dried plant, crushed plant or powder. The solvent includes water, an alcohol (for example, methanol) or an aqueous alcohol solution. After extraction, the extract solution can be separated from the solid by screening, filtration, pressurization or other suitable technique. The filtrate can be concentrated and cooled to allow A precipitate formed, thus obtaining a solid rutin-containing extract. For a description of various extraction methods, see, for example, Chinese Patent 1013579; US 2006/0099690; and Dighe et al, International Journal of Pharma and Bio Sciences, 2(1): 750-757 (2011).
典型來說,藉由這些方法製備之含固體芸香素萃取物具有高鐵含量(例如,100-300ppm)及濃密地著色(例如,黃色或棕色),特別是在源自橢圓葉鈎藤的萃取物中。芸香素可構成這些含固體芸香素萃取物的85%至90重量%。 Typically, the solid phase-containing extract prepared by these methods has a high iron content (for example, 100-300 ppm) and a dense coloring (for example, yellow or brown), particularly in extracts derived from Uncaria in. The rutin can constitute from 85% to 90% by weight of these solid rutin-containing extracts.
可將從而製備的含固體芸香素萃取物溶解在醇溶劑(較佳為甲醇或乙醇)中,以獲得一粗芸香素萃取物溶液。例如,每1毫升溶劑可溶解0.05-0.13克的固體萃取物。該粗萃取物溶液可例如在大氣壓下進一步濃縮,以減少其體積例如4至10倍。可根據描述在下列的混合物之想要的體積及成分來預定該粗萃取物溶液的最後體積。 The thus prepared solid rutin-containing extract may be dissolved in an alcohol solvent (preferably methanol or ethanol) to obtain a crude rutin extract solution. For example, 0.05 to 0.13 grams of solid extract can be dissolved per 1 milliliter of solvent. The crude extract solution can be further concentrated, for example, at atmospheric pressure to reduce its volume by, for example, 4 to 10 times. The final volume of the crude extract solution can be predetermined according to the desired volume and composition of the mixture described below.
將酸及選擇性C1-C4醇(例如,甲醇、乙醇、丙醇或正丁醇)加入至上述粗芸香素萃取物溶液以獲得一混合物。水亦可包含在該混合物中。 An acid and a selective C1-C4 alcohol (for example, methanol, ethanol, propanol or n-butanol) are added to the above crude rutin extract solution to obtain a mixture. Water can also be included in the mixture.
所使用的酸係選自於抗壞血酸、檸檬酸、酒石酸、沒食子酸及蘋果酸。其以約1-15%(例如,1-10%,或1-5%,以上述使用來製備該粗芸香素萃取物溶液的含固體芸香素萃取物之重量計)加入至該粗芸香素萃取物溶液。 The acid used is selected from the group consisting of ascorbic acid, citric acid, tartaric acid, gallic acid and malic acid. It is added to the crude rutin by about 1-15% (for example, 1-10%, or 1-5%, based on the weight of the solid rutin-containing extract used to prepare the crude rutin extract solution) Extract solution.
該混合物必需包含至少一種C1-C4醇。例如,如上所述,可使用甲醇或乙醇(即C1-C4醇)從該含固體芸香素萃取物製得該粗芸香素萃取物溶液。可不需要對該粗芸香素 萃取物溶液加入額外C1-C4醇。在某些情況中,為了獲得包含8%至30%(w/v)含固體芸香素萃取物的混合物,可例如以該含固體芸香素萃取物的2-12倍(v/w)加入C1-C4醇、C1-C4醇水溶液或C1-C4醇與水。所加入的額外C1-C4醇可與用來製得該粗芸香素萃取物溶液之醇相同或不同。 The mixture must contain at least one C1-C4 alcohol. For example, as described above, the crude rutin extract solution can be prepared from the solid rutin-containing extract using methanol or ethanol (i.e., C1-C4 alcohol). No need to treat the crude rutin The extract solution was added with additional C1-C4 alcohol. In some cases, in order to obtain a mixture comprising 8% to 30% (w/v) of the solid rutin-containing extract, C1 may be added, for example, 2-12 times (v/w) of the solid rutin-containing extract. - C4 alcohol, aqueous solution of C1-C4 alcohol or C1-C4 alcohol and water. The additional C1-C4 alcohol added may be the same or different from the alcohol used to prepare the crude rutin extract solution.
芸香素以不同水合物存在,諸如單水合物、二水合物及三水合物。已知無水物及單水合物不穩定。因此,以在純化製程期間藉由與水水合來製備相對穩定的二水合物或三水合物為較佳。此外,可將水加入至該粗芸香素萃取物溶液。其可分別地加入。其亦可以C1-4醇水溶液之形式加入。該水對C1-C4醇的比率可係1:1至5:1,例如,1:1至3:1。如上述提到,最後混合物較佳包含8%至30%(w/v)的含固體芸香素萃取物。 The rutin is present in different hydrates such as monohydrate, dihydrate and trihydrate. Anhydrates and monohydrates are known to be unstable. Therefore, it is preferred to prepare a relatively stable dihydrate or trihydrate by hydration with water during the purification process. Further, water may be added to the crude rutin extract solution. It can be added separately. It can also be added in the form of a C1-4 aqueous alcohol solution. The ratio of the water to the C1-C4 alcohol may be from 1:1 to 5:1, for example, from 1:1 to 3:1. As mentioned above, the final mixture preferably comprises from 8% to 30% (w/v) of the solid phase-containing extract.
然後,讓該包含粗芸香素萃取物溶液、C1-C4醇、酸及選擇性水之混合物靜置沉澱,例如,以形成結晶。例如,該混合物可經進一步濃縮,及攪拌該經濃縮的混合物及讓其冷卻以形成沉澱。可藉由任何合適的技術收集沉澱物,例如,過濾、以醇及/或水沖洗、及乾燥。 Then, the mixture containing the crude rutin extract solution, the C1-C4 alcohol, the acid, and the selective water is allowed to stand for precipitation, for example, to form crystals. For example, the mixture can be further concentrated, and the concentrated mixture is stirred and allowed to cool to form a precipitate. The precipitate can be collected by any suitable technique, for example, filtration, rinsing with alcohol and/or water, and drying.
該沉澱物(即,富芸香素萃取物)可包含97%至99%的芸香素(如藉由HPLC測量)及少於20的ppm鐵(即,少於10 ppm)。其亦具有低呈色,例如,該萃取物在550奈米處的吸收度低於0.2。其亦可包含5%至10重量%的水。該富芸香素萃取物可具有任何顆粒尺寸,例如,5微米或較小。例如,其可具有奈米尺寸顆粒。 The precipitate (i.e., the rutin-rich extract) may comprise 97% to 99% of rutin (as measured by HPLC) and less than 20 ppm of iron (i.e., less than 10 ppm). It also has a low coloration, for example, the extract has an absorbance below 0.25 at 550 nm. It may also contain from 5% to 10% by weight of water. The eucalyptus extract may have any particle size, for example, 5 microns or less. For example, it can have nano-sized particles.
藉由上述方法製備的富芸香素萃取物對多種應用有用。其可配製成醫藥組合物,例如,藥物。其亦可使用作為營養補充品或食物添加劑。 The eucalyptus extract prepared by the above method is useful for a variety of applications. It can be formulated into a pharmaceutical composition, for example, a drug. It can also be used as a nutritional supplement or as a food additive.
下列特定實施例欲解釋為僅闡明用,及無論如何不以任何方法限制本揭示的剩餘部分。沒有進一步詳細闡述,咸信熟習該項技術者可根據於此之說明將本發明使用至其最大程度。於本文中所引用的全部公告其全文藉此以參考方式併入本文。 The following specific examples are to be construed as illustrative only and in no way limiting the remainder of the disclosure. Without further elaboration, the skilled artisan can use the invention to its fullest extent in accordance with the description herein. All publications cited herein are hereby incorporated by reference in their entirety.
藉由下列程序獲得描述在下列實施例1-4中之鐵含量、純度及吸收度值: The iron content, purity and absorbance values described in the following Examples 1-4 were obtained by the following procedure:
準確地獲得1.0克樣品及硫酸化。將2毫升鹽酸加入至殘餘物。然後乾燥樣品,及在加入10毫升水與一滴鹽酸後於沸水中加熱。在冷卻後,將體積準確地調整至10.0毫升,然後過濾過0.45微米過濾器。藉由ICP分析測量在該樣品溶液中的鐵濃度。 Accurately obtained 1.0 gram of sample and sulfated. 2 ml of hydrochloric acid was added to the residue. The sample was then dried and heated in boiling water after the addition of 10 ml of water and a drop of hydrochloric acid. After cooling, the volume was accurately adjusted to 10.0 ml and then filtered through a 0.45 micron filter. The iron concentration in the sample solution was measured by ICP analysis.
將1.0克樣品溶解在15毫升二甲基甲醯胺(DMF)中。在以DMF將體積調整至20.0毫升後,讓該溶液過濾過0.45微米過濾器。在550奈米下,使用1.0公分的路徑長度來測量該經過濾的樣品之吸收度。 A 1.0 gram sample was dissolved in 15 ml of dimethylformamide (DMF). After the volume was adjusted to 20.0 ml with DMF, the solution was filtered through a 0.45 micron filter. At 550 nm, the absorbance of the filtered sample was measured using a path length of 1.0 cm.
根據EP專題著作芸香苷三水合物、相關物質之液相層析法進行HPLC分析。簡單地說,使用在下列提出的試劑及條件:測試溶液:將0.10克欲檢驗的物質溶解在20毫升甲醇中及以動相B稀釋至100.0毫升。 HPLC analysis was carried out according to liquid chromatography of the EP monograph rutin trihydrate and related substances. Briefly, the reagents and conditions set forth below were used: Test solution: 0.10 g of the substance to be tested was dissolved in 20 ml of methanol and diluted to 100.0 ml with phase B.
參考溶液(a):將10.0毫克芸香苷三水合物CRS溶解在10.0毫升甲醇中。 Reference solution (a): 10.0 mg of rutin trihydrate CRS was dissolved in 10.0 ml of methanol.
參考溶液(b):以動相B將1.0毫升參考溶液(a)稀釋至50.0毫升。 Reference solution (b): 1.0 ml of the reference solution (a) was diluted to 50.0 ml with phase B.
- 尺寸:1=0.25公尺,i.d.=4.0毫米, - Size: 1 = 0.25 m, i.d. = 4.0 mm,
- 靜相:色層分析用之辛基矽烷基矽凝膠(5微米) - Static phase: octyl sulfonyl group gel for chromatography (5 micron)
- 溫度:30℃ - Temperature: 30 ° C
- 動相A:混合5體積的四氫呋喃與95體積15.6克/升的磷酸二氫鈉溶液,以磷酸調整至pH 3.0。 - Phase A: Mix 5 volumes of tetrahydrofuran with 95 volumes of 15.6 g/L sodium dihydrogen phosphate solution and adjust to pH 3.0 with phosphoric acid.
- 動相B:混合40體積的四氫呋喃與60體積15.6克/升溶液的磷酸二氫鈉,以磷酸調整至pH 3.0。 - Phase B: Mix 40 volumes of tetrahydrofuran with 60 volumes of 15.6 g/L solution of sodium dihydrogen phosphate to adjust to pH 3.0 with phosphoric acid.
流速:1毫升/分鐘。 Flow rate: 1 ml/min.
偵測:分光光度計在280奈米下。 Detection: The spectrophotometer is at 280 nm.
注射:20微升。 Injection: 20 microliters.
在下列實施例1-4中所使用的酸及醇係從Wako Pure Chemical Industries,Ltd.(Osaka)獲得:抗壞血酸(最少99.5% 1級);檸檬酸(最少98.0%特級);蘋果酸(最少99.0%特級);沒食子酸(98.0-103.0% 1級);酒石酸(最少99.0% 1級);甲醇(最少99.5% 1級);乙醇(最少99.5%特級);正丙醇(最少99.7%特級);正丁醇(最少99.0%特級)。 The acids and alcohols used in the following Examples 1-4 were obtained from Wako Pure Chemical Industries, Ltd. (Osaka): ascorbic acid (minimum 99.5% grade 1); citric acid (minimum 98.0% grade); malic acid (minimum) 99.0% premium); gallic acid (98.0-103.0% grade 1); tartaric acid (minimum 99.0% grade 1); methanol (minimum 99.5% grade 1); ethanol (minimum 99.5% grade); n-propanol (minimum 99.7) % extra grade); n-butanol (minimum 99.0% premium).
使用習知的程序,以水及/或醇萃取橢圓葉鈎藤的莖及葉以獲得含固體芸香素萃取物。將三組含固體芸香素萃取物(每組50克)溶解在600毫升甲醇中及在30-35℃下攪拌二小時。過濾每種溶液及在大氣壓下濃縮,以產生300毫升的粗芸香素萃取物溶液。 The stems and leaves of Uncaria serrata were extracted with water and/or alcohol using a conventional procedure to obtain a solid rutin extract. Three groups of solid rutin-containing extracts (50 g each) were dissolved in 600 ml of methanol and stirred at 30-35 ° C for two hours. Each solution was filtered and concentrated under atmospheric pressure to give 300 ml of a crude rutin extract solution.
從而製備的含固體芸香素萃取物包含85-90%(w/w)的芸香素及100-200 ppm的鐵。其當溶解在有機溶劑中時發展出暗棕色及在DMF中於550奈米處之平均吸收度係0.8-1.3。資料總整理在下列表1中。 The solid-containing musk extract thus prepared contains 85-90% (w/w) of rutin and 100-200 ppm of iron. It develops a dark brown color when dissolved in an organic solvent and an average absorbance of 0.8-1.3 at 550 nm in DMF. The data is summarized in Table 1 below.
在大氣壓下濃縮三組粗芸香素萃取物溶液(每組皆從將50克含固體芸香素萃取物溶解在600毫升甲醇(MeOH)中獲得),以提供300毫升體積。讓每種濃縮物接收0、1.0或5.0克的抗壞血酸及每種經進一步濃縮以提供150毫升的體積。在藉由冷卻結晶後,藉由過濾接著以甲醇沖洗收集經純化的芸香素結晶。在60℃下乾燥該經純化的芸香素5小時,及如上所述般分析。結果總整理在下列表2中。在結晶程序期間加入抗壞血酸會以劑量相依方式減少殘餘鐵及減低在550奈米處的吸收度。 Three sets of crude rutin extract solutions were concentrated under atmospheric pressure (each group was obtained by dissolving 50 g of the solid rutin-containing extract in 600 ml of methanol (MeOH)) to provide a volume of 300 ml. Each concentrate was allowed to receive 0, 1.0 or 5.0 grams of ascorbic acid and each was further concentrated to provide a volume of 150 milliliters. After crystallization by cooling, the purified rutin crystals were collected by filtration followed by washing with methanol. The purified rutin was dried at 60 ° C for 5 hours and analyzed as described above. The results are summarized in Table 2 below. The addition of ascorbic acid during the crystallization procedure reduces residual iron in a dose-dependent manner and reduces the absorbance at 550 nm.
將二組500毫升粗芸香素萃取物溶液(其係將25克含固體芸香素萃取物溶解在乙醇(EtOH)中獲得)每組在大氣壓下濃縮,以提供100毫升的體積。讓每組濃縮物接收25毫升包含0或0.5克抗壞血酸的水。在藉由攪拌及冷卻結晶後,藉由過濾,接著以15毫升95%乙醇沖洗收集經純化的芸香素結晶。在60℃下乾燥該經純化的芸香素5小時及如上所述般分析。結果總整理在下列表3中。抗壞血酸的效應明顯不如當在結晶過程中使用甲醇的情況般(參見上述)。 Two groups of 500 ml of the crude rutin extract solution (which was obtained by dissolving 25 g of the solid rutin extract in ethanol (EtOH)) were concentrated under atmospheric pressure to provide a volume of 100 ml. Each set of concentrate was allowed to receive 25 ml of water containing 0 or 0.5 grams of ascorbic acid. After crystallization by stirring and cooling, the purified rutin crystals were collected by filtration, followed by rinsing with 15 ml of 95% ethanol. The purified rutin was dried at 60 ° C for 5 hours and analyzed as described above. The results are summarized in Table 3 below. The effect of ascorbic acid is significantly less than when methanol is used during crystallization (see above).
藉由將25克含固體芸香素萃取物溶解在300毫升MeOH中製備二組粗芸香素萃取物溶液。每組萃取物在大氣壓下濃縮以提供43毫升的體積。讓每組濃縮物接收包含0或0.5克抗壞血酸的丙醇水溶液(正丙醇:水=1:1;總共200毫升)。在藉由攪拌及冷卻結晶後,藉由過濾收集經純化的芸香素結晶。以25毫升正丙醇接著水沖洗芸香素結晶。在80℃下乾燥該經純化的芸香素6小時及分析。分析結果總整理在下列表4中。抗壞血酸減少殘餘鐵及減低該經純化的芸香素在550奈米處之吸收度。 Two sets of crude rutin extract solutions were prepared by dissolving 25 grams of the solid rutin extract in 300 milliliters of MeOH. Each set of extract was concentrated under atmospheric pressure to provide a volume of 43 ml. Each set of concentrate was allowed to receive an aqueous solution of propanol containing 0 or 0.5 grams of ascorbic acid (n-propanol: water = 1:1; total 200 ml). After crystallization by stirring and cooling, the purified rutin crystals were collected by filtration. The rutin crystals were rinsed with 25 ml of n-propanol followed by water. The purified rutin was dried at 80 ° C for 6 hours and analyzed. The results of the analysis are summarized in Table 4 below. Ascorbic acid reduces residual iron and reduces the absorbance of the purified rutin at 550 nm.
藉由將25克含固體芸香素萃取物溶解在300毫升MeOH中製備四種粗芸香素萃取物溶液每種。每種萃取物溶液在大氣壓下濃縮以提供43毫升的體積。讓每種濃縮物接收包含0、0.25、0.5或2.5克抗壞血酸的正丁醇水溶液(水:正丁醇=133:67毫升)。在藉由攪拌及冷卻結晶後,藉由過濾收集經純化的芸香素結晶,然後以25毫升正丁醇接著以100毫升水沖洗。在80℃下乾燥該經純化的芸香素6小時及如上所述般分析。分析結果總整理在表5中。抗壞血酸減少殘餘鐵及減低該經純化的芸香素在550奈米處之吸收度。 Four crude rutin extract solutions were prepared by dissolving 25 grams of the solid rutin extract in 300 milliliters of MeOH. Each extract solution was concentrated under atmospheric pressure to provide a volume of 43 ml. Each concentrate was allowed to receive an aqueous solution of n-butanol (water: n-butanol = 133: 67 ml) containing 0, 0.25, 0.5 or 2.5 grams of ascorbic acid. After crystallization by stirring and cooling, the purified rutin crystals were collected by filtration, followed by rinsing with 25 ml of n-butanol followed by 100 ml of water. The purified rutin was dried at 80 ° C for 6 hours and analyzed as described above. The results of the analysis are summarized in Table 5. Ascorbic acid reduces residual iron and reduces the absorbance of the purified rutin at 550 nm.
藉由將25克如在實施例1中描述般獲得之含固體芸香素萃取物溶解於300毫升MeOH中來製備七種粗芸香素萃取物溶液每種。在大氣壓下濃縮該萃取物以提供每種的體積43毫升。讓每種濃縮物接收包含酒石酸、檸檬酸、蘋果酸或沒食子酸(其量顯示在下列表6中)的丁醇水溶液(水:正丁醇=133:67毫升)。 Each of the seven crude rutin extract extract solutions was prepared by dissolving 25 grams of the solid rutin-containing extract obtained as described in Example 1 in 300 ml of MeOH. The extract was concentrated under atmospheric pressure to provide a volume of 43 ml each. Each concentrate was subjected to an aqueous butanol solution (water: n-butanol = 133: 67 ml) containing tartaric acid, citric acid, malic acid or gallic acid (the amounts are shown in Table 6 below).
在藉由攪拌及冷卻該濃縮物而結晶後,藉由過濾收集該經純化的芸香素結晶。以25毫升正丁醇接著以100毫升水沖洗該經純化的芸香素。在80℃下乾燥經純化的芸香素6小時及如上所述般分析。結果顯示在表6中。除了沒食子酸外,全部其它酸皆減少殘餘鐵及減低該經純化的芸香素在550奈米處之吸收度。 After crystallization by stirring and cooling the concentrate, the purified rutin crystals were collected by filtration. The purified rutin was rinsed with 25 ml of n-butanol followed by 100 ml of water. The purified rutin was dried at 80 ° C for 6 hours and analyzed as described above. The results are shown in Table 6. With the exception of gallic acid, all other acids reduced residual iron and reduced the absorbency of the purified muscimol at 550 nm.
描述在實施例2及3中的結果指示出丁醇與抗壞血酸 之組合係最有效減低鐵含量及在550奈米處顯示出吸收度的黃色顏色二者。 The results described in Examples 2 and 3 indicate butanol and ascorbic acid The combination is the most effective to reduce both the iron content and the yellow color that exhibits absorbance at 550 nm.
使用多種沒有任何酸的溶劑獲得經純化的芸香素。已觀察到丁醇水溶液及乙醇水溶液提供較好的芸香素產率(如與其它溶劑比較)。參見下列表7。 Purified rutin was obtained using a variety of solvents without any acid. It has been observed that aqueous butanol and aqueous ethanol provide better yields of rutin (as compared to other solvents). See list 7 below.
在本專利說明書中所揭示的全部特徵可以任何組合結合。在本專利說明書中所揭示的每種特徵可藉由另一種提供相同、同等或類似目的的特徵置換。因此,除非其它方面有明確地描述,否則所揭示的每種特徵僅係同等或類似特徵的通用系列之實施例。 All of the features disclosed in this patent specification can be combined in any combination. Each feature disclosed in this patent specification can be replaced by another feature that provides the same, equivalent, or similar purpose. Therefore, unless expressly stated otherwise, each feature disclosed is merely an embodiment of a generic series of equivalent or similar features.
熟習該項技術者可從上述容易地查明本發明的基本特徵,及可沒有離開其精神及範圍製得本發明的多種改變及修改以讓其適應多種用途及條件。因此,其它具體實例亦在本申請專利範圍內。 A person skilled in the art can readily ascertain the basic characteristics of the invention from the above, and various changes and modifications of the invention can be made without departing from the spirit and scope thereof. Therefore, other specific examples are also within the scope of the present patent application.
Claims (21)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW101138967A TWI533875B (en) | 2012-10-22 | 2012-10-22 | Rutin-rich extract and method of making same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW101138967A TWI533875B (en) | 2012-10-22 | 2012-10-22 | Rutin-rich extract and method of making same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW201416081A TW201416081A (en) | 2014-05-01 |
| TWI533875B true TWI533875B (en) | 2016-05-21 |
Family
ID=51293511
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW101138967A TWI533875B (en) | 2012-10-22 | 2012-10-22 | Rutin-rich extract and method of making same |
Country Status (1)
| Country | Link |
|---|---|
| TW (1) | TWI533875B (en) |
-
2012
- 2012-10-22 TW TW101138967A patent/TWI533875B/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| TW201416081A (en) | 2014-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9827262B2 (en) | Rutin-rich extract and method of making same | |
| CN102631379B (en) | Preparation method of taxus chinensis active extract and application thereof in fungus resistance | |
| CN101787061B (en) | Application of Quzhazhigan in preparation of preparations for preventing and treating cardiac-cerebral ischemia diseases, and preparation method thereof | |
| CN110101728B (en) | Combined extraction method of purslane polysaccharide and total flavonoids based on micelle medium treatment | |
| CN107652337B (en) | Method for extracting and preparing anthocyanin such as black rice, black beans, purple potatoes, roses, peonies and the like | |
| CN103833718A (en) | Preparation method and application of proanthocyanidin derivative | |
| CN101091734A (en) | Method for preparing extractive of pubescent angelica root coumarin | |
| TWI533875B (en) | Rutin-rich extract and method of making same | |
| CN105153253A (en) | Purple sweet potato anthocyanin extraction process | |
| CN119157794A (en) | Preparation method of Sophora japonica bud extract, product and application thereof | |
| CN100554261C (en) | A kind of preparation method of ampelopsin | |
| CN100490821C (en) | New use of tremella heteropolysaccharide or its extract | |
| CN104559302B (en) | A kind of extraction of carthamin yellow and process for purification | |
| KR100817876B1 (en) | Separation of Proanthocyanidins from Pine Bark | |
| CN105541932B (en) | Benzyl carbinol glycoside compound extracted from field thistle and its production and use | |
| CN104398619A (en) | Fevervine extract and applications thereof | |
| CN105287659B (en) | Loropetalum wood extract and its medical usage containing chinic acid class and glucoside compound | |
| CN106905391A (en) | A kind of Anthocyanin from Blueberry extracting and developing purification process | |
| CN101732419A (en) | Application and preparation method of extract from fructus polygoni orientalis | |
| CN102119993A (en) | Preparation method of onion extract, application of onion extract for prolonging life of Caenorhabditis elegans and food containing onion extract | |
| CN107626220B (en) | Method for promoting dissolution of flavone or glycoside compounds and application thereof | |
| CN103893234A (en) | Safflower injection, preparation method and content determination method | |
| CN103919800B (en) | A kind of application of glucosan | |
| CN107674127A (en) | The preparation of spina date seed polysaccharide and the application in antineoplastic is prepared | |
| CN117959754A (en) | A sugar alcohol solvent and its application in preparing products containing ginkgo leaf extract |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |